Cybin to Provide Business Update on February 17, 2021 Conference Call Cybin Inc. a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will conduct a conference call and webcast to review its financial results and provide a business update as follows: A replay of the conference call will be available for two weeks after the call’s completion by dialing 512-2921 or 317-6671 . The conference ID for the … Date A replay of the conference call will be available for two weeks after the call’s completion by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (International). The conference ID for the replay is 13716476. The archived webcast will be available for 30 days on: www.cybin.com/investor-relations .